Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Lanar

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Infection and Immunity|September 24, 2008
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmissionGregory S Noland, Brett Hendel-Paterson, Xinan M Min, et al.
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Infection and Immunity|January 24, 2008
Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1Ariane Rodríguez, Jaap Goudsmit, Arjen Companjen, et al.
The Journal of Infectious Diseases|April 17, 2014
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigensBartholomew N Ondigo, James S Hodges, Kathleen F Ireland, et al.
Vaccine|December 23, 2017
Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccineStephen A Kaba, Christopher P Karch, Labdhi Seth, et al.
Plos One|November 13, 2012
Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccineStephen A Kaba, Margaret E McCoy, Tais A P F Doll, et al.
Nature Medicine|November 2, 2010
A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopesIsamu Z Hartman, AeRyon Kim, Robert J Cotter, et al.
Vaccine|April 10, 2009
Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trialKirsten E Lyke, Modibo Daou, Issa Diarra, et al.
Infection and Immunity|May 16, 2002
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coliSheetij Dutta, P V Lalitha, Lisa A Ware, et al.
Infectious Agents and Cancer|July 30, 2010
Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control studyAmolo S Asito, Erwan Piriou, Peter Sumba Odada, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Infection and Immunity|September 24, 2008
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmissionGregory S Noland, Brett Hendel-Paterson, Xinan M Min, et al.
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Infection and Immunity|January 24, 2008
Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1Ariane Rodríguez, Jaap Goudsmit, Arjen Companjen, et al.
The Journal of Infectious Diseases|April 17, 2014
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigensBartholomew N Ondigo, James S Hodges, Kathleen F Ireland, et al.
Vaccine|December 23, 2017
Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccineStephen A Kaba, Christopher P Karch, Labdhi Seth, et al.
Plos One|November 13, 2012
Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccineStephen A Kaba, Margaret E McCoy, Tais A P F Doll, et al.
Nature Medicine|November 2, 2010
A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopesIsamu Z Hartman, AeRyon Kim, Robert J Cotter, et al.
Vaccine|April 10, 2009
Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trialKirsten E Lyke, Modibo Daou, Issa Diarra, et al.
Infection and Immunity|May 16, 2002
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coliSheetij Dutta, P V Lalitha, Lisa A Ware, et al.
Infectious Agents and Cancer|July 30, 2010
Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control studyAmolo S Asito, Erwan Piriou, Peter Sumba Odada, et al.
Pageof 7